Last reviewed · How we verify
Chinese traditional medicine XH1 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Chinese traditional medicine XH1 (Chinese traditional medicine XH1) — Haining Health-Coming Biotech Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chinese traditional medicine XH1 TARGET | Chinese traditional medicine XH1 | Haining Health-Coming Biotech Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chinese traditional medicine XH1 CI watch — RSS
- Chinese traditional medicine XH1 CI watch — Atom
- Chinese traditional medicine XH1 CI watch — JSON
- Chinese traditional medicine XH1 alone — RSS
Cite this brief
Drug Landscape (2026). Chinese traditional medicine XH1 — Competitive Intelligence Brief. https://druglandscape.com/ci/chinese-traditional-medicine-xh1. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab